Research Frontiers (REFR) Cash & Equivalents (2010 - 2026)

Research Frontiers has reported Cash & Equivalents for 17 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Cash & Equivalents fell 3.9% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 3.9% YoY) and the FY2025 annual result came in at $664299.0, down 66.69% from the prior year.
• Cash & Equivalents climbed to $1.3 million in Q1 2026 per REFR's latest filing, from $664299.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $4.8 million in Q3 2022 and troughed at $524985.0 in Q3 2023.
• A 5-year average of $2.0 million and a median of $1.9 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents soared 2224.19% in 2022, then slumped 89.06% in 2023.
• Over 5 years, Cash & Equivalents stood at $4.2 million in 2022, then plunged by 41.48% to $2.5 million in 2023, then fell by 19.46% to $2.0 million in 2024, then plunged by 66.69% to $664299.0 in 2025, then jumped by 95.7% to $1.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.3 million, $664299.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.